Microfluidics Market set to rise $56.9 billion by 2030, as Adoption of Sustainable Materials hits transformation groun

According to a recent research, Industry revenue for Microfluidics is expected to rise to $56.9 billion by 2030 from $26.2 billion of 2023. The revenue growth of industry players is estimated to average at 11.7% annually for period 2023 to 2030. Growing end-industry applications in major countries like U.S., Germany and Japan, is driving the market demand high.

Research Study analyse the new revenue pockets, emerging markets, competition landscape, opportunities & niche insights for Product Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microfluidic Flow Controllers), Application (Point-of-Care Diagnostics, Drug Delivery Systems, Lab-on-a-Chip, Clinical Diagnostics) and End-Use (Healthcare, Pharmaceuticals, Biotechnology, Chemical Analysis).

Regional Analysis

North America and Asia-Pacific are the two most active and leading regions in the market. In the Asia Pacific region the field of microfluidics is experiencing growth. Especially in China and Japan. This is attributed to an increasing need for tools and progress, in biotechnology. Both local and international companies are actively involved in research and development well as establishing strategic collaborations to cater to the healthcare requirements of the region.

With challenges like high manufacturing costs, complex regulatory landscape and challenges in scaling up production, Microfluidics market supply chain from material supplier to end user is expected to evolve & expand further; and industry players will make strategic advancement in emerging markets including India, Brazil and Singapore for revenue diversification and TAM expansion. Companies are investigating eco biodegradable materials for microfluidic devices in response, to environmental issues.

Industry Leadership and Strategies

The Microfluidics market is characterized by intense competition, with a number of leading players such as Agilent Technologies, Fluidigm, Bio-Rad, Becton Dickinson, Cepheid, Roche Diagnostics, Danaher Corporation, Micronit, Dolomite Microfluidics, Illumina, PerkinElmer and Merck Millipore. These players are pushing & penetrating the market with their strategies.

• Application Area Leading Providers Provider Strategies
• Point-of-Care Diagnostics Cepheid, Roche Diagnostics Focus on rapid, portable devices for decentralized healthcare
• Drug Delivery Systems Becton Dickinson, Fluidigm Developing devices for precise, targeted drug administration
• Lab-on-a-Chip Bio-Rad, Agilent Technologies Providing integrated solutions for streamlined lab workflows
• Environmental Analysis Micronit, Dolomite Microfluidics Offering compact devices for accurate chemical analysis in field settings

About DataString Consulting

DataString Consulting assist companies in strategy formulations & roadmap creation including TAM expansion, revenue diversification strategies and venturing into new markets; by offering in depth insights into developing trends and competitor landscapes as well as customer demographics. Our customized & direct strategies, filters industry noises into new opportunities; and reduces the effective connect time between products and its market niche.

DataString Consulting offers complete range of market research and business intelligence solutions for both B2C and B2B markets all under one roof. DataString’s leadership team has more than 30 years of combined experience in Market & business research and strategy advisory across the world. Our Industry experts and data aggregators continuously track & monitor high growth segments within more than 15 industries and 60 sub-industries.